Shanghai Pharmaceuticals Holding Co (STU:S1R) Cyclically Adjusted Book per Share: €1.36 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:S1R Shanghai Pharmaceuticals Holding Co Ltd STU:S1R
80 GF Score
Price €1.22
GF Value €1.49
! 5 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Book per Share?

Shanghai Pharmaceuticals Holding Co STU:S1R -0.81% 80 Cyclically Adjusted Book per Share is €1.36 as of Jun. 2026. GuruFocus rates STU:S1R with a GF Score™ of 80/100 and a GF Value™ of €1.49. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted book value per share for the three months ended in Jun. 2026 was €2.706. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.36 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Cyclically Adjusted Book Growth Rate was 5.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shanghai Pharmaceuticals Holding Co was 16.90% per year. The lowest was 5.10% per year. And the median was 12.10% per year.

As of today (2026-09-01), Shanghai Pharmaceuticals Holding Co's current stock price is €1.22. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €1.36. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio of today is 0.90.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Pharmaceuticals Holding Co was 3.38. The lowest was 0.90. And the median was 1.52.


Shanghai Pharmaceuticals Holding Co  (STU:S1R) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.22/1.36
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Pharmaceuticals Holding Co was 3.38. The lowest was 0.90. And the median was 1.52.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Book per Share Related Terms


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Book per Share Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 1.25 1.17 1.16 1.16

Shanghai Pharmaceuticals Holding Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 1.21 1.16 1.23 1.36

STU:S1R vs MCK, COR, CAH: Cyclically Adjusted Book per Share Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PB Ratio falls into.


STU:S1R
80GF Score
Shanghai Pharmaceuticals Holding Co Ltd STU:S1R
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Pharmaceuticals Holding Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.706/116.0564*116.0564
=2.706

Current CPI (Jun. 2026) = 116.0564.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.567 102.400 1.776
201612 1.611 102.600 1.822
201703 1.648 103.200 1.853
201706 1.583 103.100 1.782
201709 1.583 104.100 1.765
201712 1.622 104.500 1.801
201803 1.696 105.300 1.869
201806 1.742 104.900 1.927
201809 1.695 106.600 1.845
201812 1.753 106.500 1.910
201903 1.861 107.700 2.005
201906 1.810 107.700 1.950
201909 1.838 109.800 1.943
201912 1.881 111.200 1.963
202003 1.933 112.300 1.998
202006 1.894 110.400 1.991
202009 1.946 111.700 2.022
202012 2.006 111.500 2.088
202103 2.153 112.662 2.218
202106 2.169 111.769 2.252
202109 2.254 112.215 2.331
202112 2.413 113.108 2.476
202203 3.248 114.335 3.297
202206 2.497 114.558 2.530
202209 2.576 115.339 2.592
202212 2.456 115.116 2.476
202303 2.513 115.116 2.534
202306 2.344 114.558 2.375
202309 2.375 115.339 2.390
202312 2.376 114.781 2.402
202403 2.417 115.227 2.434
202406 2.420 114.781 2.447
202409 2.436 115.785 2.442
202412 2.536 114.893 2.562
202503 2.512 115.116 2.533
202506 2.445 114.907 2.469
202509 2.444 115.471 2.456
202512 2.481 115.832 2.486
202603 2.616 116.303 2.610
202606 2.706 116.056 2.706

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.36 mean?
Shanghai Pharmaceuticals Holding Co (STU:S1R) has a Cyclically Adjusted Book per Share of €1.36 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share too high?
Shanghai Pharmaceuticals Holding Co's current Cyclically Adjusted Book per Share is €1.36. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share compare to MCK and COR?
Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Book per Share of €1.36 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Distribution company?
A good Cyclically Adjusted Book per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Cyclically Adjusted Book per Share is €1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (STU:S1R) has a current Cyclically Adjusted Book per Share of €1.36. The stock's GF Value™ is €1.49, compared to a current price of €1.22 — trading 18.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €1.36. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (STU:S1R), the current Cyclically Adjusted Book per Share is €1.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (STU:S1R) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of €1.22 is trading 18.1% below its estimated GF Value™ of €1.49.

Key valuation signals for STU:S1R:

  • Cyclically Adjusted Book per Share: €1.36
  • GF Value™: €1.49 vs. price of €1.22 (18.1% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the STU:S1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Other Exchanges 02607:Hong Kong601607:China
Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
80GF Score

Get the complete analysis for STU:S1R

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.22
Price
€1.49
GF Value